In this article, we propose analytic review (AR) as a solution to the problem of misreporting statistical results in psychological science. AR requires authors submitting manuscripts for publication to also submit the data file and syntax used during analyses. Regular reviewers or statistical experts then review reported analyses in order to verify that the analyses reported were actually conducted and that the statistical values are accurately reported. We begin by describing the problem of misreporting in psychology and introduce the basic AR process. We then highlight both primary and secondary benefits of adopting AR and describe different permutations of the AR system, each of which has its own strengths and limitations. We conclude by attempting to dispel three anticipated concerns about AR: that it will increase the workload placed on scholars, that it will infringe on the traditional peer-review process, and that it will hurt the image of the discipline of psychology. Although implementing AR will add one more step to the bureaucratic publication process, we believe it can be implemented in an efficient manner that would greatly assist in decreasing the frequency and impact of misreporting while also providing secondary benefits in other domains of scientific integrity.

Download full-text PDF

Source
http://dx.doi.org/10.1177/1745691614549257DOI Listing

Publication Analysis

Top Keywords

analytic review
8
review solution
8
misreporting statistical
8
statistical psychological
8
psychological science
8
problem misreporting
8
secondary benefits
8
misreporting
4
solution misreporting
4
statistical
4

Similar Publications

Most people with mental health needs cannot access treatment; among those who do, many access services only once. Accordingly, single-session interventions (SSIs) may help bridge the treatment gap. We conducted the first umbrella review synthesizing research on SSIs for mental health problems and service engagement in youth and adults.

View Article and Find Full Text PDF

European Society of Cardiology quality indicators for the management of acute coronary syndrome.

Eur Heart J Acute Cardiovasc Care

January 2025

Centro Nacional de Investigaciones Cardiovasculares Carlos III (CNIC), Madrid, Spain.

Background: Closing the evidence-practice gap for the treatment of acute coronary syndrome (ACS) is central to improving quality of care. Under the European Society of Cardiology (ESC) framework, we aimed to develop updated quality indicators (QIs) for the evaluation of quality of care and outcomes for patients with ACS.

Methods: A Working Group of experts including members of the ESC Clinical Practice Guidelines Task Force for ACS, Acute CardioVascular Care Association and European Association of Percutaneous Cardiovascular Interventions followed the ESC methodology for QI development.

View Article and Find Full Text PDF

The Effectiveness of Nonpharmacological Interventions to Reduce Procedural Pain of Pediatric Oncology Patients: A Systematic Review and Meta-analysis.

Cancer Nurs

January 2025

Author Affiliations: Departments of Pediatric Nursing (Drs Gürcan, Karataş, and Atay Turan) and Internal Disease Nursing (Dr Özer), Faculty of Nursing, Akdeniz University, Antalya, Türkiye.

Background: Relieving procedural pain in pediatric oncology is an important facilitator of the cancer treatment process.

Objective: To synthesize the effect of nonpharmacological interventions on reducing the procedural pain of pediatric oncology patients in randomized controlled trials.

Methods: A meta-analysis and systematic review for randomized controlled trials.

View Article and Find Full Text PDF

Rapamycin, also known as sirolimus, has demonstrated great potential for application in longevity medicine. However, the dynamics of low-dose rapamycin bioavailability, and any differences in bioavailability for different formulations (e.g.

View Article and Find Full Text PDF

Background: With the expiration of patents for multiple biotherapeutics, biosimilars are gaining traction globally as cost-effective alternatives to the original products. Glycosylation, a critical quality attribute, makes glycosimilarity assessment pivotal for biosimilar development. Given the complexity of glycoanalytical profiles, assessing glycosimilarity is nontrivial.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!